Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine: Prognostic factors and patterns of failure

• Published in: Strahlentherapie und Onkologie 2003-04, Vol.179 (4), p.241-248
• Main Authors: NOËL, Georges, HABRAND, Jean-Louis, BOISSERIE, Gilbert, BEAUDRE, Anne, GABORIAUD, Geneviève, GUEDEA, Ferran, PETRIZ, Lourdes, MAZERON, Jean-Jacques, JAUFFRET, Eric, DE CREVOISIER, Renaud, DEDERKE, Sygon, MAMMAR, Hamid, HAIE-MEDER, Christine, PONTVERT, Dominique, HASBOUN, Dominique, FERRAND, Régis
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biological and medical sciences; Cervical Vertebrae; Chondrosarcoma - mortality; Chondrosarcoma - radiotherapy; Chordoma - mortality; Chordoma - radiotherapy; Data Interpretation, Statistical; Diseases of the osteoarticular system. Orthopedic treatment; Dose Fractionation; Female; Follow-Up Studies; Humans; Male; Medical sciences; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Photons - therapeutic use; Prognosis; Prospective Studies; Protons - therapeutic use; Radiotherapy Dosage; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Sex Factors; Skull Base Neoplasms - mortality; Skull Base Neoplasms - radiotherapy; Spinal Neoplasms - mortality; Spinal Neoplasms - radiotherapy; Time Factors
• ISSN: 0179-7158; 1439-099X
• DOI: 10.1007/s00066-003-1065-5

Prospective analysis of local tumor control, survival and treatment complications in 67 consecutive patients treated with fractionated photon and proton radiation for chordoma or chondrosarcoma of the base of the skull and the cervical spine. Between December 1995 and January 2000, 67 patients with a median age of 52 years (range: 14-85 years), were treated at the Centre de Protonthérapie d'Orsay (CPO), France, using the 201-MeV proton beam, 49 for chordoma and 18 for chondrosarcoma. Irradiation combined high-energy photons and protons. Photons represented two thirds of the total dose and protons one third. The median total dose delivered within gross tumor volume (GTV) was 67 Cobalt Gray Equivalents (CGE; range: 60-70 CGE). Within a median follow-up of 29 months (range: 4-71 months), the 3-year local control rates were 71% and 85% for chordomas and chondrosarcomas, respectively, and the 3-year overall survival rates 88% and 75%, respectively. 14 tumors (21.5%) failed locally (eight within the GTV, four within the clinical target volume [CTV], and two without further assessment). Seven patients died from their tumor and another one from a nonrelated condition (pulmonary embolism). The maximum tumor diameter and, similarly, the GTV were larger in relapsing patients, compared with the rest of the population: 56 mm vs 44 mm (p = 0.024) and 50 ml vs 22 ml (p = 0.0083), respectively. In univariate analysis, age < or = 52 years at the time of radiotherapy (p = 0.002), maximum diameter < 45 mm (p = 0.02), and GTV < 28 ml (p = 0.02) impacted positively on local control. On multivariate analysis, only age was an independent prognostic factor of local control. In chordomas and chondrosarcomas of the skull base and cervical spine, combined photon and proton radiation therapy offers excellent chances of cure. In two thirds of the cases, relapses are located in the GTV. Maximum diameter, GTV, and age are prognostic indicators of local control. These results should be confirmed during a longer follow-up.